Journal profile · INFECTIOUS DISEASES
Journal of Infection in Developing Countries
ISSN 1972-2680 · eISSN 2036-6590 · Journal of Infection in Developing Countries · ITALY · Founded 2007
Journal of Infection in Developing Countries: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.33; fully open access; APC charged, amount not published; median 127 days to acceptance (98 articles, last 24 months); community-reported acceptance: easy; 238 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Infection in Developing Countries is published by Journal of Infection in Developing Countries and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Antibiotic Resistance in Bacteria, Tuberculosis Research and Epidemiology and COVID-19 Clinical Research Studies, together about 23.4% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
About the Journal The Journal of Infection in Developing Countries (JIDC) is the official publication of the Journal of Infection in Developing Countries Non-Profit Organization, produced in collaboration with Linee di Confine, a Non-Profit Organization dedicated to advancing equitable access to scientific knowledge. JIDC is an independent, peer-reviewed, open-access journal governed by a distinguished international editorial board. All content is freely available to read and download at no cost, with reasonable publication fees for research articles — ensuring that scientists and researchers from resource-limited settings can participate fully in the global scientific community. The Journal publishes original research papers, research notes, and comprehensive reviews spanning multiple disciplines, including human, animal, and environmental Microbiology, Immunology, and Virology, with a focused emphasis on infections prevalent in developing countries. Priority is given to studies addressing emerging and re-emerging etiological agents, advances in diagnostic methodologies, epidemiological trends, and public health policy implications. The JIDC Mentoring System Central to JIDC's mission is its pioneering mentoring program, which sets the journal apart from other international publications. Recognizing that submitted manuscripts may require editorial refinement, JIDC maintains a dedicated Mentor Committee — a specialized team of editorial experts committed to collaborating directly with authors from developing countries to bring their work to international publication standards. This collaborative process may encompass English language editing, structural reorganization of the manuscript, and expert guidance on experimental design and methodology. Through this interactive partnership, the Mentor Committee and authors work together not only to produce manuscripts that meet the highest global standards, but also to foster the exchange of knowledge and best practices that empower researchers to publish successfully in other leading international journals. The JIDC Mentor Committee stands as a singular initiative among international scientific journals, purpose-built to bridge the editorial gap faced by researchers in developing countries. Indexing & Impact JIDC is indexed in Scopus and Thomson Reuters and carries an official Journal Citation Reports (JCR) Impact Factor. The Impact Factor for 2025 is 1.2.
From the journal's Aims & Scope
Research area (LetPub): INFECTIOUS DISEASES
Editor-in-chief Salvatore RubinoPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named Italy 26, United States 13, United Kingdom 9, Türkiye 9, India 6 (133 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology11.8%
- Tuberculosis Research and EpidemiologyMedicine5.8%
- COVID-19 Clinical Research StudiesMedicine5.8%
- Salmonella and Campylobacter epidemiologyAgricultural and Biological Sciences5.8%
- Nosocomial Infections in ICUMedicine5.7%
- Antibiotic Use and ResistanceImmunology and Microbiology5.5%
- Escherichia coli research studiesBiochemistry, Genetics and Molecular Biology4%
- SARS-CoV-2 and COVID-19 ResearchMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.33LetPub ·
- Impact factor (publisher)
- 2.51Publisher website ·
- CiteScore 2026-06
- 2.4LetPub ·
- SJR 2026-06
- 0.4LetPub ·
- SNIP 2026-06
- 0.52LetPub ·
- h-index
- 40LetPub ·
- h-index
- 86OpenAlex ·
- i10-index
- 1,735OpenAlex ·
- 2-year mean citedness
- 1.7OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 99.49%LetPub ·
Volume
- Articles per year
- 233LetPub ·
- Articles per year (publisher)
- 1Publisher website ·
Articles by year OpenAlex count · 3,857 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 153 | 153 | 21 |
| 2025 | 238 | 238 | 323 |
| 2024 | 311 | 311 | 848 |
| 2023 | 251 | 251 | 1,386 |
| 2022 | 275 | 275 | 1,830 |
| 2021 | 280 | 280 | 3,080 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
127 daysMedian, submission to acceptance · P25–P75 83 days – 187 days
- Acceptance to online
- median 215 days (98 articles)
- Submission to online
- median 363 days
- Sample
- 98 articles with submission and acceptance dates (478 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to publication (journal-reported)
- about 18 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 366 | Yes | CC BY | |
| OpenAlex | EUR 366 | — | — | |
| LetPub | EUR 366 | Yes | — | |
| Publisher website | EUR 488 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Suggested reviewers
- Required, 3
- Cover letter
- Required
Article types accepted3, with length limits
- editorialAny manuscript submitted to the journal must not be under consideration by any other journal or already published in any journal or other citable form. Submissi…Length not stated
- letters to the editorhlighting novel and important findings. Letters to the editor: The text for letters the editor should not exceed a total 1,200 words. References (not to exceed …main text ≤ 1,200 words
- original articleous "embellishments" should be avoided. Original Articles: An original article should be at least 2100 words long excluding references and title page. Manuscrip…main text ≤ 2,100 words
Policy excerpts from the journal's websiteConflicts of interest, Publication ethics, License & copyright, Peer review, Preprints, Trial registration / reporting guidelines
- Conflicts of interest
Manuscripts must not be under consideration elsewhere or already published. Model summary
Any manuscript submitted to the journal must not be under consideration by any other journal or already published in any journal or other citable form.
Source ↗Publisher website ·- Publication ethics
Ethics committee approval required; human research must comply with Helsinki Declaration; animal studies must follow internationally recognized guidelines. Model summary
Authors are expected to state that the study (where applicable) has been conducted with approval of an appropriate ethics committee. Additionally, all research carried out on humans must be in compliance with the Helsinki Declaration, and animal studies must follow internationally recognized guidelines.
Source ↗Publisher website ·- License & copyright Copyright Notice
Authors retain copyright; work licensed under Creative Commons Attribution License. Model summary
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additio…
Source ↗Publisher website ·- Peer review Overview of the publication and peer review processes
JIDC aims to provide all authors with an efficient and consistent editorial process. Submitted manuscripts will be assigned to a member of the editorial team who is an expert in the field. The editor will assess the manuscript to determine whether it is within the scope of the journal, the quality of the data presented, and the standard of presentation before sending it for peer review.
Source ↗Publisher website ·- Preprints Preprints
Preprint posting permitted prior to submission; authors must declare preprint versions and provide DOI or link at submission. Model summary
Posting of preprints prior to submission is permitted. Authors should declare any preprint versions and provide a DOI or link at the time of submission.
Source ↗Publisher website ·- Trial registration / reporting guidelines
Controlled trials must be registered in a publicly accessible registry before submission; registration number required at submission. Model summary
Protocols or reports of controlled trials of health-care interventions should be registered in a suitable publicly accessible registry before submission in JIDC. The trial registration number should be provided at the time of article submission.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Journal of Infection in Developing Countries
- Country or region
- ITALY
- Language
- English
- Founded
- 2007
- ISSN
- 1972-2680
- Electronic ISSN
- 2036-6590
- Society / sponsor
- Journal of Infection in Developing Countries Non-Profit Organization
- Latest issue on the website
- Volume 20, Issue 08 (August 2026)
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Journal of Infection in Developing Countries
What CAS zone is Journal of Infection in Developing Countries in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Infection in Developing Countries is in Zone 4 of Medicine, and in Zone 4 of the minor category Infectious Diseases. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Infection in Developing Countries?
The latest impact factor listed by LetPub is 1.33; CiteScore 2.4, h-index 86.
How long does peer review take at Journal of Infection in Developing Countries?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 127 days (interquartile range 83–187 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Infection in Developing Countries?
According to the journal's author guidelines: Suggested reviewers: Required, 3; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Infection in Developing Countries based?
Of the 133 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are Italy (26), United States (13) and United Kingdom (9). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Infection in Developing Countries?
According to LetPub and DOAJ records, Journal of Infection in Developing Countries is indexed in SCIE, Scopus and DOAJ.
Is Journal of Infection in Developing Countries open access, and what is the APC?
Journal of Infection in Developing Countries is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .